Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial

Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial

<p><strong>Background:</strong>&nbsp;Despite inhaled corticosteroid plus long-acting &beta;<sub>2</sub>-agonist (ICS/LABA) therapy, 30&ndash;50% of patients with moderate or severe asthma remain inadequately controlled. We investigated the safety and efficac...

Full description

Bibliographic Details
Main Authors: Lee, LA, Bailes, Z, Barnes, N, Boulet, L-P, Edwards, D, Fowler, A, Hanania, NA, Kerstjens, HAM, Kerwin, E, Nathan, R, Oppenheimer, J, Papi, A, Pascoe, S, Brusselle, G, Peachey, G, Sule, N, Tabberer, M, Pavord, ID
Format: Journal article
Language:English
Published: Elsevier 2020

Similar Items

Similar Items